CA Stock MarketDetailed Quotes
PREV PreveCeutical Medical Inc
- 0.025
- 0.0000.00%
15min DelayMarket Closed Jun 27 11:36 ET
13.50MMarket Cap-12500P/E (TTM)
0.000High0.000Low0Volume0.000Open0.025Pre Close0.00Turnover0.03052wk High0.00%Turnover Ratio539.90MShares0.01552wk Low-0.002EPS TTM11.82MFloat Cap0.200Historical HighLossP/E (Static)472.90MShs Float0.010Historical Low-0.003EPS LYR0.00%Amplitude--Dividend TTM-2.50P/B1Lot Size--Div YieldTTM
PreveCeutical Medical Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -69.09%153.12K | 17.93%1.06M | -21.01%228.57K | 668.10%495.4K | -45.40%173.79K | -57.32%161.06K | -58.49%897.85K | -81.50%289.37K | 79.28%-87.2K | -57.50%318.31K |
| Selling and administrative expenses | -80.30%87.67K | 26.71%833.71K | -21.80%170.73K | 157.47%445K | -14.03%107.2K | -22.33%110.79K | -61.88%657.99K | -82.44%218.33K | 70.82%172.84K | -62.22%124.69K |
| -General and administrative expense | -80.30%87.67K | 26.71%833.71K | -21.80%170.73K | 157.47%445K | -14.03%107.2K | -22.33%110.79K | -61.82%657.99K | -82.40%218.33K | 70.82%172.84K | -62.22%124.69K |
| Research and development costs | 32.40%52.38K | -10.72%153.42K | -33.09%40.28K | 114.58%39.56K | -80.35%35.14K | -81.11%38.45K | -45.47%171.85K | -80.45%60.2K | 49.28%-271.28K | -52.35%178.83K |
| Depreciation amortization depletion | 124.31%2.44K | 94.28%9.89K | 836.47%6.57K | -20.15%1.09K | -26.23%1.11K | -26.41%1.13K | -93.23%5.09K | -69.83%702 | -24.74%1.36K | -94.82%1.5K |
| -Depreciation and amortization | 124.31%2.44K | 94.28%9.89K | 836.47%6.57K | -20.15%1.09K | -26.23%1.11K | -26.41%1.13K | -93.23%5.09K | -69.83%702 | -24.74%1.36K | -94.82%1.5K |
| Other operating expenses | 9.12%10.64K | -1.80%61.79K | 8.44%10.99K | -1.26%9.75K | 128.32%30.35K | -63.88%10.7K | 34.12%62.93K | -3.63%10.14K | -10.95%9.88K | -8.97%13.29K |
| Operating profit | 69.09%-153.12K | -17.93%-1.06M | 21.01%-228.57K | -668.10%-495.4K | 45.40%-173.79K | 57.32%-161.06K | 58.49%-897.85K | 81.50%-289.37K | -79.28%87.2K | 57.50%-318.31K |
| Net non-operating interest income (expenses) | 73.25%-79.71K | 49.18%-237.27K | 268.70%283.62K | -256.28%-298.02K | -8.09%-84.76K | -1.02%-138.12K | 27.05%-466.9K | -69.64%-168.12K | 6.05%-83.65K | 74.47%-78.41K |
| Non-operating interest expense | -73.25%79.71K | -49.18%237.27K | -268.70%-283.62K | 256.28%298.02K | 8.09%84.76K | 1.02%138.12K | -27.05%466.9K | 69.64%168.12K | -6.05%83.65K | -74.47%78.41K |
| Other net income (expenses) | -63.72%-6.81K | 51.54%-185.28K | 966.78%278.84K | -195.87%-4.16K | 56.92%-158.08K | -1,758.68%-301.88K | 61.92%-382.3K | -326.89%-32.17K | -101.18%-1.41K | 64.45%-366.93K |
| Gain on sale of security | -63.72%-6.81K | 99.33%-1.42K | 1,154.09%317.65K | -529.85%-4.16K | 56.92%-158.08K | -184.74%-156.84K | -179.29%-212.64K | -259.18%-30.14K | -100.48%-660 | -256.08%-366.93K |
| Special income (charges) | --0 | -8.37%-183.86K | -1,808.31%-38.82K | --0 | --0 | 13.09%-145.04K | 86.90%-169.66K | -350.00%-2.03K | 96.06%-745 | --0 |
| -Less:Other special charges | ---- | -12.61%145.83K | --0 | ---- | ---- | -12.61%145.83K | -86.28%166.88K | 200.00%1 | ---- | ---- |
| -Less:Write off | ---- | --38.82K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | --0 | 128.40%789 | --0 | --0 | --0 | --789 | 96.48%-2.78K | -348.79%-2.03K | 96.06%-745 | --0 |
| Income before tax | 69.95%-239.64K | 15.21%-1.48M | 168.19%333.89K | -37,161.94%-797.57K | 45.44%-416.62K | -21.21%-601.06K | 54.11%-1.75M | 70.31%-489.66K | -99.52%2.15K | 63.43%-763.65K |
| Income tax | 0 | 0 | -232.96%-20.48K | 0 | ||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 69.95%-239.64K | 14.20%-1.48M | 171.16%333.89K | -37,161.94%-797.57K | 45.44%-416.62K | -21.21%-601.06K | 54.58%-1.73M | 71.44%-469.18K | -99.52%2.15K | 63.43%-763.65K |
| Net income continuous operations | 69.95%-239.64K | 14.20%-1.48M | 171.16%333.89K | -37,161.94%-797.57K | 45.44%-416.62K | -21.21%-601.06K | 54.58%-1.73M | 71.44%-469.18K | -99.52%2.15K | 63.43%-763.65K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 69.95%-239.64K | 14.20%-1.48M | 171.16%333.89K | -37,161.94%-797.57K | 45.44%-416.62K | -21.21%-601.06K | 54.58%-1.73M | 71.44%-469.18K | -99.52%2.15K | 63.43%-763.65K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 69.95%-239.64K | 14.20%-1.48M | 171.16%333.89K | -37,161.94%-797.57K | 45.44%-416.62K | -21.21%-601.06K | 54.58%-1.73M | 71.44%-469.18K | -99.52%2.15K | 63.43%-763.65K |
| Diluted earnings per share | 77.60%-0.0004 | 0.00%-0.003 | 0 | -50,100.00%-0.002 | 20.40%-0.0008 | 35.71%-0.0009 | 66.67%-0.003 | 77.50%-0.0009 | -99.60%0 | 80.00%-0.001 |
| Basic earnings per share | 77.60%-0.0004 | 0.00%-0.003 | 0 | -50,100.00%-0.002 | 20.40%-0.0008 | 35.71%-0.0009 | 66.67%-0.003 | 77.50%-0.0009 | -99.60%0 | 80.00%-0.001 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg